A prospective clinical study was performed in 70 consecutive patients with known or strong clinical suspicion of acute or relapsing multiple sclerosis. The study was designed to compare the results of standard computed tomography and high-volume . contrast-delayed scanning for the detection of enhancing lesions. In 39 cases with clinically definitive multiple sclerosis, the conventional enhanced scan was positive in 25 cases and the high-volume delay scan in 32. The high-volume enhanced scan added information in 23 of these 32 cases. In 21 cases , suspicious of multiple sclerosis but not clinically confirmed , the standard enhanced scan was positive in t wo cases and t he high-volume delay scan in five. In these cases, computed t omography was definitive in establishing the diagnosis by showing clinically unsuspected brain lesions. In 10 cases in whi ch the disease was eventually excluded , the scans were negative in all instances. For the first time, by the high-volume delayed t echnique, enhancing plaques in the cortical gray matter and in the gray / white matter regions were demonstrated. This technique is a very useful diagnostic tool, not only for morphologic assessment when multiple sclerosis is known, but for the positive diagnosis of this disease when the first clinical presentation is diagnostically uncertain .
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Neuroradiologic stud ies in patients with suspected mu ltiple sclerosis (MS) have been traditionally used mainly for exclusion of other pathology. With th e introduction of computed tomographic (CT) scanning of the brain, spec ific details of the gray and white matter can now be evaluated . It is well known that MS has several different CT appearances in patients with c lini cal evidence of cereb ral involvement [1] [2] [3] [4] . The CT scan may be normal or it may show foca l les ions with or without evidence of atrophy [1 -6] .
It is presumed that MS demyelinating plaques produce a " mild " blood-brain barrier (BBB) disruption, as manifested by a relative ly slight elevation of cerebrospinal fluid (CSF) protein . On the basis of that premi se, it was thought that a prolonged exposure of MS lesions to a high-volume sustained blood-i od ine level (3-6 mg / dl) and delayed scanning might depict areas of enh anceme nt in zones of BBB disruption not visible on standard CT.
The high-volume delayed (HVD) scan was originall y described by Hay man et al. [7] [8] [9] for the assessment of other intracranial diseases. Th e potential usefulness of this technique for the assessment of MS was also suggested by Prend es [10] and Davis et al. [11] .
Subjects and Methods
Using a protocol set up at Uni ve rsity Hospital, Unive rsit y of Western Ontario, we exam ined 70 patients with known or strong c linical suspic ion of earl y acu te or relapsing MS during a period of 14 months. Each of the 70 pati ents was scanned before cont rast medium infusion . Th en, 100 ml of Conray 400 (40 g iodine) were administered intravenously as a bolus injection. Immediate contrast CT scans were obtained . On comp letion of these scans, an add itional rapid drip of 300 ml of Hypaq ue 30 (42 g iod in e) was give n. Th e HVD AJNR :3 , May / Jun e 1982 scans were obtain ed 1 nr after tn e rapid drip in fusion. None of th ese patients had diabetes or elevated c reati nin e levels. No releva nt neuro log ic or systemi c side effec ts after contrast med ium infu sion (82 g iodin e) were detec ted .
All th ese stu dies we re done on a GE 8800 scanner using a 9 .6 sec, hig h-resolution mode. Similar wind ow setting s we re used for filmi ng th e standard and th e hi gh-volume delayed scans. Th e CT scans were evalu ated by two staff neuroradiologi sts. Special attenti on was given to differences in informati on obtained in th e hi ghvo lume delayed scan when compared with th e standard dose scan.
Results
Pati ents were divided into three groups, depend ing on th eir eventual diag nosis, on th e basis of standard cli ni cal and laboratory inform ation. [12] were used for the clin ical diagnosis and the laboratory criteria were the CSF electrophoretic changes described by Ebers and Paty [13] .
In the 32 CT-positive cases , the non enhanced scan was abnormal in 20, the conventional enhanced scan was abnormal in 25, and the HVD showed enhanci ng lesions in all 3 2 . The latter techniq ue showed important additional information in 23 (72 %) of these cases . This additional information was : (1) reinforcement of equivocal findings on standard CT scan in 17 cases (fig . 1) ; (2) enhancement of lowdensity plaques not enhanced on standard CT in 13 cases (fig. 2) ; (3) enhancement of isode nse plaques not enhanced on standard CT in nine cases (fig . 3) ; and (4) perception of low-density plaques not discernible on standard CT in four cases ( fig . 4) . In none of the 3 2 positive cases was less information observed by HVD scanning than by conventional scanning .
Group 2 : Susp ected Multiple Sclerosis
In the 21 cases of suspicious but not clinicall y confirmed intracranial MS, CT was positive in five. In these fi ve cases , The other 16 cases with negative CT scans showed a wide spectrum of sing le or multiple neurologic symptoms such as gait ataxia, bilateral optic atrophy, bilateral internuclear ophthalm oplegia, generalized parathesia, bil ateral/ lateral gaze nystagmus, etc. This group of patients remains undiagnosed .
A B A B Group 3: Multiple Sclerosis Excluded
In the 10 patients in whom MS was eventually c linically exc lud ed, CT scans of all types were negative in all cases.
Discussion
Evidence that CT is a valuable diagnostic tool in MS has been extensively reported [1, 2, 4-6, 9, 14, 15] . CT scans have been an important source of anatomic / morphologic information in patients with known disease. Enhancing white matter lesions have been described in these patients. In most reports , a relatively low rate of enhancing lesions has been d emonstrated : 24.5 % [4], 20 .8 % [6], 9 % [15] , and 12.5% [16] . Our detection rate of enhan cing lesions is substantially higher than that described previously. This disc repancy may be explained by two factors : (1) all our patients were in a state of early acute or relapsing MS and (2) we used HVD scanning .
HVD demonstrated additional MS enhancing lesions in 23 of the 32 positive cases, and it offered a positive diagnosis in nine cases (seven cases in group 1 and two cases in group 2) , in which the standard CT scans had been interpreted as normal or as showing no evid ence of active disease . HVD demonstrated areas of enhancement produced by blood-brain barrier disruption [17 , 18] in low-density or isodense MS plaques that were not seen on standard CT. We also observed enhancing MS plaques in the cerebral cortical and cortical/subcortical regions ( fig . 7) . These findings are well known to neuropathologists [19, 20] , but to our knowledge they have not been reported before in the CT literature of MS. There were strong positive clinical / CT correlations in our acute or relapsing cases of MS reinforcing the concept that the areas of enhancement are probably acute demyelinating plaques. Ultimate certainty will require comparison of the CT enhancing lesions and the corresponding biopsies or postmortem histology.
It is important to emphasize the essential role played by CT in the group of patients in whom MS was only suspected but not c linically confirmed using standard criteria . In such patients, CT suggested the diagnosis of MS by showing clinically silent and spatially separated central nervous system (CNS) lesions. Even at the time of the first clinical presentation of a single lesion such as optic neuritis ( fig. 6 ) , transverse myelitis ( fig. 5) , or a single intracranial asymptomatic plaque, CT scanning showed additional lesions that were helpful in diagnosing the disease. CT should be added to the list of laboratory studies that can aid in the diagnosis of MS .
On the basis of our experience, we regard the highvolume delayed (HVD) CT scan as the examination of choice for the detection of MS enhancing lesions. It not only increases the number of enhancing lesions detected by standard CT but demonstrates new lesions with a topography otherwise rarely observed, that is , cortical gray matter and gray matter/ white matter junction. It may suggest the diagnosis by showing clinically silent and spatially separated CNS lesions. The sequential use of CT scanning may help in understanding the morphologic evolution of enhancing, " active" MS plaques and the effects of treatment on them .
